Hess Midstream LP
HESM NYSE Crude Petroleum & Natural Gas Financials FY2017βFY2025
What Hess Midstream LP does
No business description yet.
- Legal name
- Hess Midstream LP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001193125-26-071592
0001789832
Revenue and margins
Hess Midstream LP had $1.6B of revenue in fiscal 2025, up 8.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $728M in fiscal 2025, 44.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hess Midstream LP returned $400M to shareholders in fiscal 2025, 55% of free cash flow. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Hess Midstream LP can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.2M | $3.1M | $5.4M | $4.3M | $1.9M |
| Debt incl. finance leases | $2.6B | $2.9B | $3.2B | $3.5B | $3.8B |
| Net debt / EBITDA | 2.9x | 3.0x | 3.2x | 3.1x | 3.1x |
| Current ratio | 0.8x | 0.8x | 0.7x | 0.7x | 0.8x |
| Quick ratio | 0.8x | 0.8x | 0.7x | 0.7x | 0.8x |
| Total assets | $3.5B | $3.6B | $3.8B | $4.2B | $4.4B |
| Total liabilities | $2.7B | $3.1B | $3.4B | $3.7B | $4.0B |
| Net debt (β = net cash) | $2.6B | $2.9B | $3.2B | $3.5B | $3.8B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 3 | 4 / 7 | 5 / 7 | 5 / 7 | 6 / 7 | 5 / 7 | 7 / 7 | 6 / 7 |
| Accruals ratio | β | β13.2% | β12.8% | β18.6% | β21.8% | β22.0% | β20.3% | β18.1% | β14.8% |
| Altman Z'' | β | β | β | β | β | β | β | β | β |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $580M | $713M | $848M | $1.1B | $1.2B | $1.3B | $1.3B | $1.5B | $1.6B |
| Operating income | $263M | $378M | $377M | $577M | $727M | $791M | $817M | $919M | $1.0B |
| Pretax income | $242M | $326M | $318M | $492M | $632M | $647M | $646M | $731M | $798M |
| Income tax | β | β | β$0.1M | $7.3M | $14.6M | $26.6M | $37.9M | $71.8M | $114M |
| Net income | $41.2M | $70.8M | $70.1M | $24.0M | $46.4M | $83.9M | $119M | $223M | $353M |
| Cash flow | |||||||||
| Cash from operations | $337M | $467M | $471M | $642M | $796M | $861M | $866M | $940M | $984M |
| Capital expenditure | $144M | $242M | $306M | $301M | $163M | $238M | $224M | $306M | $256M |
| Free cash flow | $192M | $225M | $164M | $341M | $632M | $623M | $643M | $634M | $728M |
| Depreciation and amortization | $117M | $127M | $143M | $157M | $166M | $181M | $193M | $203M | $214M |
| Stock-based compensation | $0.2M | $0.9M | $1.5M | $1.5M | $1.4M | $1.6M | $1.7M | $1.8M | $1.6M |
| Acquisitions | β | β | $89.2M | β | β | β | β | β | β |
| Share buybacks | β | β | β | β | $750M | $400M | $400M | $300M | $400M |
| Dividends and buybacks | β | β | β | β | $750M | $400M | $400M | $300M | $400M |
| Balance sheet | |||||||||
| Cash and short-term investments | β | $109M | $3.3M | $2.6M | $2.2M | $3.1M | $5.4M | $4.3M | $1.9M |
| Total debt | β | $981M | $1.8B | $1.9B | $2.6B | $2.9B | $3.2B | $3.5B | $3.8B |
| Finance lease liabilities | β | β | $0.0M | β | β | β | β | β | β |
| Current assets | β | $180M | $95.9M | $101M | $133M | $132M | $137M | $149M | $159M |
| Current liabilities | β | $138M | $176M | $125M | $171M | $160M | $210M | $219M | $188M |
| Property and equipment, net | β | $2.7B | $3.0B | $3.1B | $3.1B | $3.2B | $3.2B | $3.3B | $3.4B |
| Total assets | β | $3.0B | $3.3B | $3.4B | $3.5B | $3.6B | $3.8B | $4.2B | $4.4B |
| Total liabilities | β | $1.1B | $1.9B | $2.0B | $2.7B | $3.1B | $3.4B | $3.7B | $4.0B |
| Margins | |||||||||
| Operating margin | 45.4% | 53.1% | 44.4% | 52.8% | 60.4% | 62.0% | 60.6% | 61.5% | 62.2% |
| EBITDA margin | 65.5% | 70.9% | 61.2% | 67.2% | 74.2% | 76.3% | 74.8% | 75.0% | 75.4% |
| Net margin | 7.1% | 9.9% | 8.3% | 2.2% | 3.9% | 6.6% | 8.8% | 14.9% | 21.8% |
| FCF margin | 33.2% | 31.6% | 19.4% | 31.2% | 52.5% | 48.8% | 47.7% | 42.4% | 44.9% |
| Returns | |||||||||
| Return on capital employed | β | 13.3% | 12.1% | 17.7% | 21.9% | 23.1% | 22.8% | 23.4% | 24.0% |
| Return on assets | β | 2.4% | 2.2% | 0.7% | 1.4% | 2.4% | 3.2% | 5.6% | 8.3% |
| Growth | |||||||||
| Revenue growth | β | 23.0% | 19.0% | 28.7% | 10.2% | 5.9% | 5.8% | 10.9% | 8.4% |
| Net income growth | β | 71.8% | β1.0% | β65.8% | 93.3% | 80.8% | 41.4% | 88.1% | 58.2% |
| FCF growth | β | 17.0% | β27.0% | 107.3% | 85.6% | β1.5% | 3.2% | β1.4% | 14.8% |
| Financial health | |||||||||
| Net debt / EBITDA | β | 1.7x | 3.4x | 2.6x | 2.9x | 3.0x | 3.2x | 3.1x | 3.1x |
| Current ratio | β | 1.3x | 0.5x | 0.8x | 0.8x | 0.8x | 0.7x | 0.7x | 0.8x |
| Quick ratio | β | 1.3x | 0.5x | 0.8x | 0.8x | 0.8x | 0.7x | 0.7x | 0.8x |
| Capital allocation | |||||||||
| Capex / revenue | 24.9% | 33.9% | 36.1% | 27.6% | 13.6% | 18.7% | 16.6% | 20.5% | 15.8% |
| Stock comp / revenue | 0.0% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Payouts / FCF | β | β | β | β | 118.6% | 64.2% | 62.2% | 47.3% | 54.9% |
| Quality scores | |||||||||
| Piotroski F-score | β | β | 4.0 | 5.0 | 5.0 | 6.0 | 5.0 | 7.0 | 6.0 |
| Accruals ratio | β | β13.2% | β12.8% | β18.6% | β21.8% | β22.0% | β20.3% | β18.1% | β14.8% |
Source: SEC EDGAR XBRL filings (CIK 0001789832). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.